Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125316611 | 12531661 | 1 | I | 20160629 | 20160706 | 20160706 | PER | US-ELI_LILLY_AND_COMPANY-US201606010874 | ELI LILLY AND CO | 0.00 | F | Y | 98.88000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125316611 | 12531661 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | 21427 | 60 | MG | CAPSULE | QD | ||||||
| 125316611 | 12531661 | 2 | C | MELOXICAM. | MELOXICAM | 1 | 15 MG, QD | 0 | 15 | MG | QD | ||||||||
| 125316611 | 12531661 | 3 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 4000 IU, QD | 0 | 4000 | IU | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125316611 | 12531661 | 1 | Fibromyalgia |
| 125316611 | 12531661 | 2 | Product used for unknown indication |
| 125316611 | 12531661 | 3 | Vitamin D deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125316611 | 12531661 | Asthenia | |
| 125316611 | 12531661 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125316611 | 12531661 | 1 | 201604 | 0 |